Tochi Anioke

1.4k total citations
6 papers, 77 citations indexed

About

Tochi Anioke is a scholar working on Infectious Diseases, Health and Immunology. According to data from OpenAlex, Tochi Anioke has authored 6 papers receiving a total of 77 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Health and 2 papers in Immunology. Recurrent topics in Tochi Anioke's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and Vaccine Coverage and Hesitancy (3 papers). Tochi Anioke is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and Vaccine Coverage and Hesitancy (3 papers). Tochi Anioke collaborates with scholars based in United States, Netherlands and Finland. Tochi Anioke's co-authors include Catherine Jacob-Dolan, Jingyou Yu, Ai‐ris Y. Collier, Dan H. Barouch, Ricardo Aguayo, Katherine McMahan, Abishek Chandrashekar, Lisa H. Tostanoski, Mazuba Siamatu and Dylan B. Tierney and has published in prestigious journals such as Journal of Virology, Science Translational Medicine and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Tochi Anioke

5 papers receiving 76 citations

Peers

Tochi Anioke
Ricardo Aguayo United States
Michael de St. Aubin United States
Ka-Li Zhu China
Victoria Giffin United States
Eva Bednarski United States
Ricardo Aguayo United States
Tochi Anioke
Citations per year, relative to Tochi Anioke Tochi Anioke (= 1×) peers Ricardo Aguayo

Countries citing papers authored by Tochi Anioke

Since Specialization
Citations

This map shows the geographic impact of Tochi Anioke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tochi Anioke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tochi Anioke more than expected).

Fields of papers citing papers by Tochi Anioke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tochi Anioke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tochi Anioke. The network helps show where Tochi Anioke may publish in the future.

Co-authorship network of co-authors of Tochi Anioke

This figure shows the co-authorship network connecting the top 25 collaborators of Tochi Anioke. A scholar is included among the top collaborators of Tochi Anioke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tochi Anioke. Tochi Anioke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Anioke, Tochi, Christina M. Stuart, Kathryn Colborn, et al.. (2025). Seasonality of surgical site infection rates across a broad surgical sample and diverse health system. American Journal of Infection Control. 53(5). 559–564.
2.
Dagotto, Gabriel, Robert C. Patio, David Li, et al.. (2024). Adenoviral-vectored neoantigen vaccine augments hyperexpanded CD8+ T cell control of tumor challenge in mice. Journal for ImmunoTherapy of Cancer. 12(12). e009644–e009644. 2 indexed citations
3.
Collier, Ai‐ris Y., Catherine Brown, Katherine McMahan, et al.. (2022). Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant. Science Translational Medicine. 14(641). eabn6150–eabn6150. 43 indexed citations
4.
Dagotto, Gabriel, John D. Ventura, David R. Martinez, et al.. (2022). Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex. npj Vaccines. 7(1). 125–125. 4 indexed citations
5.
Nkolola, Joseph P., Jingyou Yu, Huahua Wan, et al.. (2022). A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques. Science Translational Medicine. 14(665). eabo6160–eabo6160. 4 indexed citations
6.
Vidal, Samuel J., Ai‐ris Y. Collier, Jingyou Yu, et al.. (2021). Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera. Journal of Virology. 95(14). e0040421–e0040421. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026